FDA: No Decision on Whether to Pull Diabetes Drug Avandia Off the Market (HealthDay)

HealthDay - MONDAY, Feb. 22 (HealthDay News) -- The U.S. Food and Drug Administration on Monday said it was still reviewing documents that examine whether the blockbuster type 2 diabetes drug Avandia raises users' odds for heart attack and heart failure and should be removed from the market.